Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73,819,979
-
Total 13F shares
-
6,797,455
-
Share change
-
+5,487,455
-
Total reported value
-
$265,100,000
-
Put/Call ratio
-
0.05%
-
Price per share
-
$39.00
-
Number of holders
-
43
-
Value change
-
+$214,009,957
-
Number of buys
-
41
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q4 2019
As of 31 Dec 2019,
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,797,455 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, VHCP Management III, LLC, RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, BOXER CAPITAL, LLC, TIEDEMANN ADVISORS, LLC, Invesco Ltd., and FRANKLIN RESOURCES INC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.